Crossmark

Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis

Crossref DOI link: https://doi.org/10.1016/j.farma.2024.04.023

Published Print: 2024-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cortell-Fuster, Clara

Martínez-Gómez, María Amparo

Cercós-Lleti, Ana Cristina

Climente-Martí, Mónica

Díaz-Corpas, Tania

Mateu-Puchades, Almudena

Revert-Fernández, Ángeles
License Information

Text and Data Mining valid from 2024-06-01

Text and Data Mining valid from 2024-06-01

Version of Record valid from 2024-04-29
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2024.04.023

Content Type: article

Copyright: © 2024 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.